Intracellular polyamine levels, S-phase fraction and aneuploidy in patients with chronic myeloid leukemia in chronic and accelerated phase.

被引：0
|
作者：
Tripathi, AK [1 ]
Chaturvedi, R [1 ]
Tekwani, BL [1 ]
Ahmad, R [1 ]
Asim, M [1 ]
Singh, RL [1 ]
机构：
[1] KGs Med Coll, Dept Med, Div Haematooncol, Lucknow, Uttar Pradesh, India
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
692
引用
收藏
页码：3868S / 3868S
页数：1
相关论文
共 50 条
  • [41] Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib
    Ganesan, Prasanth
    Rajendranath, Rejiv
    Kandakumar, Vignesh
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF PEDIATRICS, 2015, 82 (03): : 235 - 239
  • [42] Asciminib in the treatment of chronic myeloid leukemia in chronic phase
    Costa, Alessandro
    Scalzulli, Emilia
    Bisegna, Maria Laura
    Breccia, Massimo
    FUTURE ONCOLOGY, 2025, 21 (07) : 815 - 831
  • [43] Treatment of Chronic Phase Chronic Myeloid Leukemia with Imatinib
    Prasanth Ganesan
    Rejiv Rajendranath
    Vignesh Kandakumar
    Tenali Gnana Sagar
    The Indian Journal of Pediatrics, 2015, 82 : 235 - 239
  • [44] Comparison of the Outcome between Newly Diagnosed Patients in the Accelerated Phase and Chronic Phase with Chronic Myeloid Leukemia Treated with Frontline Tyrosine Kinase Inhibitors
    Jiang, Qian
    Yu, Lu
    Qin, Ya-Zhen
    Lai, Yue-Yun
    Huang, Xiao-Jun
    BLOOD, 2017, 130
  • [45] Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia
    Tripathi, Payal
    Tripathi, Anil Kumar
    Kumar, Ashutosh
    Ahmad, Rizwan
    Balapure, Anil Kumar
    Vishwakerma, Achchhe Lal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2009, 25 (01): : 10 - 16
  • [46] Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia
    Payal Tripathi
    Anil Kumar Tripathi
    Ashutosh Kumar
    Rizwan Ahmad
    Anil Kumar Balapure
    Achchhe Lal Vishwakerma
    Indian Journal of Hematology and Blood Transfusion, 2009, 25 : 10 - 16
  • [47] S-PHASE FRACTION IS NOT CORRELATED WITH NUCLEOSIDE TRANSPORT IN ACUTE MYELOID-LEUKEMIA CELLS
    POWELL, BL
    WHITE, JC
    GREGORY, BW
    BROCKSCHMIDT, JK
    RHINEHARDTCLARK, A
    LYERLY, ES
    CHORLEY, HM
    CAPIZZI, RL
    LEUKEMIA, 1991, 5 (07) : 598 - 601
  • [48] Incidence and management of myelosuppression in patients with chronic- and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate
    Akard, Luke
    Kantarjian, Hagop M.
    Nicolini, Franck E.
    Wetzler, Meir
    Lipton, Jeffrey H.
    Baccarani, Michele
    Khoury, H. Jean
    Kurtin, Sandra
    Li, Elizabeth
    Munteanu, Mihaela
    Cortes, Jorge
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 654 - 665
  • [49] Minimal cross-intolerance with nilotinib in patients with chronic myeloid leukemia in chronic or accelerated phase who are intolerant to imatinib
    Cortes, Jorge E.
    Hochhaus, Andreas
    le Coutre, Philipp D.
    Rosti, Gianantonio
    Pinilla-Ibarz, Javier
    Jabbour, Elias
    Gillis, Kathryn
    Woodman, Richard C.
    Blakesley, Rick E.
    Giles, Francis J.
    Kantarjian, Hagop M.
    Baccarani, Michele
    BLOOD, 2011, 117 (21) : 5600 - 5606
  • [50] Probability and impact of obtaining a cytogenetic response to imatinib as initial therapy for chronic myeloid leukemia (CML) in chronic phase.
    Druker, BJ
    Gathmann, I
    Bolton, AE
    Larson, RA
    BLOOD, 2003, 102 (11) : 182A - 182A
12345